Oracle Alpha »

Entrada Therapeutics shares owned by Oracle Alpha

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Oracle Alpha from 13F filings

Historical chart of Oracle Alpha investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Oracle Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Oracle Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $189k 13k 15.09

More positions owned by Oracle Alpha

Intel Corporation (INTC)
NVIDIA Corporation (NVDA)
Gitlab (GTLB)
Samsara (IOT)
Eli Lilly & Co. (LLY)
Thermo Fisher Scientific (TMO)
Snowflake Inc Cl A (SNOW)
Tesla Motors (TSLA)
Synchrony Financial (SYF)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Coinbase Global (COIN)
Procore Technologies (PCOR)
Brighthouse Finl (BHF)
Hess (HES)

View all positions for Oracle Alpha

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
T. Rowe Price Associates
Redmile Group
Vanguard Group
Wellington Management Company
72 Investment Holdings
Charles Schwab Investment Management
TD Asset Management
Bank of New York Mellon
Moore Capital Management
Barclays
Corton Capital
Rhumbline Advisers
Bank of America Corporation

View all funds holding Entrada Therapeutics